Abstract:SUMOylation, which is a type of post-translational modification that involves covalent conjugation of small ubiquitin-like modifier (SUMO) proteins to target substrates, regulates various important molecular and cellular processes, including transcription, the cell cycle, cell signaling, and DNA synthesis and repair. Newly synthesized SUMO is immature and cleaved by the SUMO-specific protease family, resulting in exposure of the C-terminal Gly–Gly motif to become the mature form. In the presence of ATP, mature SUMO is conjugated with the activating enzyme E1 through the cysteine residue of E1, followed by transfer to the cysteine residue of E2-conjugating enzyme Ubc9 in humans that recognizes and modifies the lysine residue of a substrate protein. E3 SUMO ligases promote SUMOylation. SUMOylation is a reversible modification and mediated by SUMO-specific proteases. Cumulative studies have indicated that SUMOylation affects the functions of protein substrates in various manners, including cellular localization and protein stability. Gene knockout studies in mice have revealed that several SUMO cycling machinery proteins are crucial for the development and differentiation of various cell lineages, including immune cells. Aberrant SUMOylation has been implicated in several types of diseases, including cancers, cardiovascular diseases, and autoimmune diseases. This review summarizes the biochemistry of SUMO modification and the general biological functions of proteins involved in SUMOylation. In particular, this review focuses on the molecular mechanisms by which SUMOylation regulates the development, maturation, and functions of immune cells, including T, B, dendritic, and myeloid cells. This review also discusses the underlying relevance of disruption of SUMO cycling and site-specific interruption of SUMOylation on target proteins in immune cells in diseases, including cancers and infectious diseases.

Abnormal Protein SUMOylation in Liver Disease: Novel Target for Therapy

The role and mechanism of SUMO modification in liver disease

SUMOylation: A Link to Future Therapeutics.

Protein SUMOylation and disease

Role and mechanism of post-translational SUMOylation in atherosclerosis

[Sumoylation and Its Role in Hematological Disease].

Protein SUMOylation Modification and Its Associations with Disease

Mechanisms and functions of SUMOylation in health and disease: a review focusing on immune cells

SUMOylation in Neurological Diseases

SUMOylation in Viral Replication and Antiviral Defense

Functional Proteomics Study Reveals SUMOylation of TFII-I is Involved in Liver Cancer Cell Proliferation

DeSUMOylation: An Important Therapeutic Target and Protein Regulatory Event.

Post-Translational Modification of SUMOylation and Cancer: A Brief Review

Sumoylation As an Emerging Target in Therapeutics Against Cancer

The SUMO Family: Mechanisms and Implications in Thyroid Cancer Pathogenesis and Therapy

Small-Molecule Inhibitors Targeting Protein SUMOylation As Novel Anticancer Compounds.

SUMOylation Homeostasis in Tumorigenesis

The Important Roles of Protein SUMOylation in the Occurrence and Development of Leukemia and Clinical Implications

The Critical Roles of the SUMO-Specific Protease SENP3 in Human Diseases and Clinical Implications

Sumoylation as an Emerging Target in Therapeutics against Cancer.

SUMO: A new perspective to decipher fibrosis